-
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
12 Feb 2026 21:15 GMT
…
Russo Partners
David.Schull@russopartnersllc.com
Ignacio.Guerrero-Ros@russopartnersllc.com
858.717.2310 …
-
BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting
12 Feb 2026 12:00 GMT
… Partners
Nic Johnson
nic.johnson@russopartnersllc.com
1.303.482.6405 Media … Partners
David Schull
david.schull@russopartnersllc.com
1.858.717.2310 Source …
-
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
11 Feb 2026 13:03 GMT
…
(858) 717-2310
david.schull@russopartnersllc.com
-
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
11 Feb 2026 12:00 GMT
…
Russo Partners
David.Schull@russopartnersllc.com
Ignacio.Guerrero-Ros@russopartnersllc.com
858.717.2310 …
-
NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production
11 Feb 2026 02:43 GMT
… . For more information, visit www.russopartnersllc.com.
About NurExone
NurExone Biologic Inc …
-
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
10 Feb 2026 21:05 GMT
… , LLC
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com
(858) 717-2310 or …
-
Kincell Bio Announces Partnership with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases
10 Feb 2026 13:39 GMT
… LLC
ignacio.guerrero-ros@russopartnersllc.com
tierney.sovic@russopartnersllc.com
KEYWORD: UNITED STATES NORTH …
-
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial
10 Feb 2026 13:39 GMT
…
David.Schull@russopartnersllc.com
858-717-2310Rachelle Babb
rachelle.babb@russopartnersllc.com
929-325 …
-
FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University
10 Feb 2026 13:30 GMT
…
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com For more information on A4LI …
-
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
09 Feb 2026 12:00 GMT
…
Russo Partners
David.Schull@russopartnersllc.com
Ignacio.Guerrero-Ros@russopartnersllc.com
858.717.2310 …